Table 3.
NS/NT | NS/PH | Decomp/PH | |
n=5 | n=5 | n=5 | |
S100B (ng/mL) | 0.26±0.45 | 0.04±0.06 | 0.48±0.39 |
GFAP (ng/mL) | 0.00±0.00 | 0.10±0.18 | 0.00±0.00 |
NSE (ng/mL) | 0.12±0.27 | 0.00±0.00 | 0.19±0.42 |
BUN (mg/dL) | |||
BSLN | 6.2±2.4 | 9.2±3.3 | 5.4±3.2 |
EOS | 6.2±2.4 | 9.2±3.3 | 7.0±3.5 |
PFC1 | 7.4±2.1 | 9.8±3.4 | 7.2±3.6 |
PFC2 | 8.8±2.5 | 11.4±3.6 | 8.8±3.8 |
PFC4 | 10.6±2.3 | 13.8±3.8 | 11.4±4.3 |
END PFC | 12.0±2.5 | 15.4±3.6 | 13.2±4.3 |
EHC | 13.4±2.3 | 15.0±5.5 | 11.4±3.2 |
Final | 8.2±3.0 | 9.4±3.4 | 6.6±4.3 |
CREA (mg/dL) | |||
BSLN | 1.3±0.2 | 1.3±0.2 | 1.0±0.2 |
EOS | 1.3±0.23 | 1.3±0.23 | 1.3±0.111,2 |
PFC1 | 1.2±0.23 | 1.3±0.23 | 1.2±0.211,2 |
PFC2 | 1.2±0.23 | 1.2±0.13 | 1.2±0.211,2 |
PFC4 | 1.2±0.23 | 1.2±0.23 | 1.1±0.21,2 |
END PFC | 1.2±0.2 | 1.1±0.13 | 1.0±0.12 |
EHC | 1.1±0.23 | 1.2±0.13 | 1.1±0.21,2 |
Final | 1.1±0.1 | 1.2±0.1 | 0.9±0.2 |
AST (U/L) | |||
BSLN | 22.0±5.2 | 22.6±5.4 | 19.2±2.5 |
EOS | 23.8±8.2 | 22.6±4.9 | 20.6±3.4 |
PFC1 | 22.4±4.0 | 23.2±7.0 | 36.6±15.0 |
PFC2 | 20.4±4.3 | 23.4±4.9 | 114.6±131.0 |
PFC4 | 25.8±8.7 | 27.6±8.4 | 296.4±375.6 |
END PFC | 33.8±18.63 | 35.0±15.43 | 472.2±603.511,2 |
EHC | 42.0±22.33 | 51.2±34.63 | 426.0±395.911,2 |
Final | 353.6±278.93 | 550.6±223.4 | 794.0±600.01 |
ALT (U/L) | |||
BSLN | 53.0±15.2 | 57.2±14.7 | 54.4±7.9 |
EOS | 51.0±15.3 | 59.4±15.3 | 53.0±7.3 |
PFC1 | 51.8±15.4 | 62.4±11.3 | 46.8±4.5 |
PFC2 | 52.2±13.5 | 59.4±13.8 | 54.6±9.2 |
PFC4 | 51.4±13.7 | 58.4±14.7 | 70.4±24.2 |
END PFC | 53.2±12.4 | 54.2±10.7 | 75.6±32.9 |
EHC | 53.0±12.0 | 57.6±13.7 | 88.2±18.3 |
Final | 153.4±55.6 | 151.8±39.5 | 202.8±80.7 |
Results are presented as mean±SD. Statistical significance is achieved by p<0.05. Values significantly different from BSLN are denoted in italics. Superscript numbers indicate value is significantly different from the corresponding column listed.
ALT, alanine aminotransferase; AST, aspartate aminotransferase; BSLN, baseline; BUN, blood urea nitrogen; CREA, creatinine; EHC, end of hospital care; END PFC, end of prolonged field care; EOS, end of shock; GFAP, glial fibrillary acidic protein; NS, non-shock; NSE, neuron-specific enolase; NT, normotensive; PFC, prolonged field care; PH, permissive hypotension.